Fusion Antibodies Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

AIM:FAB Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
16 Oct 24	BuyUK£3,504	Adrian Kinkaid	Individual	83,728	UK£0.042
09 Sep 24	BuyUK£3,106	Richard Buick	Individual	94,825	UK£0.033
05 Sep 24	BuyUK£3,804	Adrian Kinkaid	Individual	120,000	UK£0.032
22 Jul 24	BuyUK£4,815	Simon Douglas	Individual	150,000	UK£0.032

Insider Trading Volume

Insider Buying: FAB insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of FAB?
Owner Type	Number of Shares	Ownership Percentage
Public Companies	256,894	0.268%
State or Government	3,197,865	3.33%
Individual Insiders	3,887,615	4.05%
General Public	30,273,509	31.6%
Institutions	58,337,029	60.8%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 61.4%.

Top Shareholders

Top 25 shareholders own 64.47% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
17%	Jarvis Securities plc, Asset Management Arm	16,278,557	UK£1.1m	760%	0.11%
6.67%	Unicorn Asset Management Ltd.	6,397,290	UK£428.6k	0%	0.07%
4.92%	Amati Global Investors Ltd.	4,716,463	UK£316.0k	0%	0.07%
4.68%	Rathbones Investment Management Limited	4,488,286	UK£300.7k	-0.28%	no data
3.35%	HBOS Investment Fund Managers Limited	3,216,625	UK£215.5k	62.7%	no data
3.33%	Invest Northern Ireland	3,197,865	UK£214.3k	0%	no data
2.95%	Barclays Bank PLC, Wealth and Investment Management Division	2,831,185	UK£189.7k	46.7%	no data
2.28%	Clarendon Fund Managers Limited	2,190,350	UK£146.8k	0%	no data
2.16%	IG Group Holdings Plc, Asset Management Arm	2,074,868	UK£139.0k	45.8%	0.01%
2.1%	Crescent Capital	2,013,382	UK£134.9k	0%	100.0%
1.55%	Octopus Investments Limited	1,484,434	UK£99.5k	0%	0.01%
1.5%	Gresham House Asset Management Limited	1,441,735	UK£96.6k	0%	0.01%
1.21%	Colin Walsh	1,162,500	UK£77.9k	93.8%	no data
1.18%	HSBC Global Asset Management (UK) Limited	1,128,955	UK£75.6k	1,180%	no data
1.14%	Marex Spectron Group Limited, Asset Management Arm	1,089,561	UK£73.0k	70.8%	0.34%
1.12%	Ramsey Crookall & Co Limited, Asset Management Arm	1,070,500	UK£71.7k	35.5%	0.02%
1.04%	Richard Buick	1,000,000	UK£67.0k	42.9%	no data
1.02%	Fidelity International Ltd	980,808	UK£65.7k	14.2%	no data
0.93%	Evelyn Partners Investment Management LLP	896,748	UK£60.1k	-1.05%	no data
0.85%	Simon Douglas	818,865	UK£54.9k	47.2%	no data
0.78%	Adrian Kinkaid	750,000	UK£50.2k	12.6%	no data
0.74%	Qubis Limited	709,375	UK£47.5k	0%	0.05%
0.69%	Merrill Lynch & Co. Inc., Banking Investments	657,325	UK£44.0k	0%	no data
0.66%	Canaccord Genuity Asset Management Limited	636,666	UK£42.7k	0%	no data
0.65%	M. D. Barnard & Co. Ltd., Asset Management Arm	625,000	UK£41.9k	0%	0.04%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/23 13:10
End of Day Share Price	2024/12/20 00:00
Earnings	2024/09/30
Annual Earnings	2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Fusion Antibodies plc is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Robin Davison	Allenby Capital Limited